164 related articles for article (PubMed ID: 24618370)
1. Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.
Augustin M; Herberger K; Kroeger K; Muenter KC; Goepel L; Rychlik R
Int Wound J; 2016 Feb; 13(1):82-7. PubMed ID: 24618370
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with leg ulcers: results from CHALLENGE, a double-blind randomised controlled trial.
Meaume S; Dompmartin A; Lok C; Lazareth I; Sigal M; Truchetet F; Sauvadet A; Bohbot S;
J Wound Care; 2017 Jul; 26(7):368-379. PubMed ID: 28704156
[TBL] [Abstract][Full Text] [Related]
3. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.
Münter KC; Meaume S; Augustin M; Senet P; Kérihuel JC
J Wound Care; 2017 Feb; 26(Sup2):S4-S15. PubMed ID: 28182533
[TBL] [Abstract][Full Text] [Related]
4. Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.
Lázaro-Martínez JL; Edmonds M; Rayman G; Apelqvist J; Van Acker K; Hartemann A; Martini J; Lobmann R; Bohbot S; Kerihuel JC; Piaggesi A
J Wound Care; 2019 Jun; 28(6):358-367. PubMed ID: 31166858
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of polyabsorbent TLC-NOSF dressings on chronic wounds: a prospective, observational, multicentre study of 1140 patients.
Dissemond J; Lützkendorf S; Dietlein M; Neßeler I; Becker E; Möller U; Thomassin L; Bohbot S; Münter KC
J Wound Care; 2020 Jun; 29(6):350-361. PubMed ID: 32530781
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of UrgoStart Plus dressings in real-life conditions: results of a prospective multicentre study on 961 patients.
Augustin M; Keuthage W; Lobmann R; Lützkendorf S; Groth H; Möller U; Thomassin L; Bohbot S; Dissemond J; Blome C
J Wound Care; 2021 Dec; 30(12):966-978. PubMed ID: 34881999
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials.
Sigal ML; Addala A; Maillard H; Chahim M; Sala F; Blaise S; Dalac S; Meaume S; Bohbot S; Tumba C; Tacca O
J Wound Care; 2019 Mar; 28(3):164-175. PubMed ID: 30840551
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA.
Guest JF; Ruiz FJ; Mihai A; Lehman A
Curr Med Res Opin; 2005 Jan; 21(1):81-92. PubMed ID: 15881478
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
[TBL] [Abstract][Full Text] [Related]
10. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.
Meaume S; Truchetet F; Cambazard F; Lok C; Debure C; Dalac S; Lazareth I; Sigal ML; Sauvadet A; Bohbot S; Dompmartin A;
Wound Repair Regen; 2012; 20(4):500-11. PubMed ID: 22681551
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.
Lobmann R; Augustin M; Lawall H; Tigges W; Potempa C; Thiem H; Fietz C; Rychlik RP
J Wound Care; 2019 Dec; 28(12):808-816. PubMed ID: 31825772
[TBL] [Abstract][Full Text] [Related]
14. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
15. VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers.
Iglesias C; Nelson EA; Cullum NA; Torgerson DJ;
Health Technol Assess; 2004 Jul; 8(29):iii, 1-105. PubMed ID: 15248939
[TBL] [Abstract][Full Text] [Related]
16. A budget impact analysis comparing a Hydrofiber® ; dressing to an alginate dressing in managing exuding venous leg ulcers in France.
Yan S; Colin X; Coudray-Omnès C; Guido-Morin P; Kommala DR
Int Wound J; 2014 Jun; 11(3):304-13. PubMed ID: 23020759
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.
Schmutz JL; Meaume S; Fays S; Ourabah Z; Guillot B; Thirion V; Collier M; Barrett S; Smith J; Bohbot S; Dompmartin A
Int Wound J; 2008 Jun; 5(2):172-82. PubMed ID: 18494623
[TBL] [Abstract][Full Text] [Related]
18. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
[TBL] [Abstract][Full Text] [Related]
19. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
Saco M; Howe N; Nathoo R; Cherpelis B
Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
[TBL] [Abstract][Full Text] [Related]
20. Cost-effective use of silver dressings for the treatment of hard-to-heal chronic venous leg ulcers.
Jemec GB; Kerihuel JC; Ousey K; Lauemøller SL; Leaper DJ
PLoS One; 2014; 9(6):e100582. PubMed ID: 24945381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
